A randomized, double-blind, placebo-controlled cross over trial of the effect on quality of life (QOL) of continuing dexamethasone beyond 24 hours following moderately emetogenic chemotherapy in women with breast cancer.
J. L. Vardy
No relevant relationships to disclose
G. R. Pond
No relevant relationships to disclose
A. Dodd
No relevant relationships to disclose
D. Warr
No relevant relationships to disclose
B. Seruga
No relevant relationships to disclose
M. J. Clemons
No relevant relationships to disclose
L. Bordeleau
No relevant relationships to disclose
I. Tannock
No relevant relationships to disclose